Market Research Logo

Canada Cataract Surgery Devices Market Outlook to 2022

Canada Cataract Surgery Devices Market Outlook to 2022

Summary

GlobalData’s new report, Canada Cataract Surgery Devices Market Outlook to 2022, provides key market data on the Canada Cataract Surgery Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Phacoemulsification Equipment and Ophthalmic Viscoelastic Devices (OVD).

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Cataract Surgery Devices market segements - Phacoemulsification Equipment and Ophthalmic Viscoelastic Devices (OVD).
  • Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
  • 2015 company shares and distribution shares data for each of the market segements.
  • Global corporate-level profiles of key companies operating within the Canada Cataract Surgery Devices market.
  • Key players covered include Alcon, Inc., Abbott Medical Optics, Inc., Bausch & Lomb Incorporated, Carl Zeiss AG and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cataract Surgery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cataract Surgery Devices Market, Canada
3.1 Cataract Surgery Devices Market, Canada, Revenue ($m), 2008-2015
3.2 Cataract Surgery Devices Market, Canada, Revenue ($m), 2015-2022
3.2.1 Ophthalmic Viscoelastic Devices (OVD) Market, Canada, Revenue ($m), by Segment, 2008-2015
3.2.2 Ophthalmic Viscoelastic Devices (OVD) Market, Canada, Revenue ($m), by Segment, 2015-2022
3.3 Cataract Surgery Devices Market, Canada, Volume (Units), 2008-2015
3.4 Cataract Surgery Devices Market, Canada, Volume (Units), 2015-2022
3.4.1 Ophthalmic Viscoelastic Devices (OVD) Market, Canada, Volume (Units), by Segment, 2008-2015
3.4.2 Ophthalmic Viscoelastic Devices (OVD) Market, Canada, Volume (Units), by Segment, 2015-2022
3.5 Cataract Surgery Devices Market, Canada, Average Price ($), 2008-2022
3.6 Cataract Surgery Devices Market, Canada, Distribution Share by Revenue ($m), 2014-2015
3.7 Cataract Surgery Devices Market, Canada, Company Share by Revenue ($m), 2015
4 Overview of Key Companies in Canada, Cataract Surgery Devices Market
4.1 Abbott Medical Optics, Inc.
4.1.1 Company Overview
4.2 Bausch & Lomb Incorporated
4.2.1 Company Overview
4.3 Carl Zeiss AG
4.3.1 Company Overview
4.4 Alcon, Inc.
4.4.1 Company Overview
5 Cataract Surgery Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Private Equity
6.1.1 Valeant Pharma Rejects Joint Takeover Bid from Takeda Pharma and TPG Capital Management
7 Recent Developments
7.1 Corporate Communications
7.1.1 Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer
7.1.2 Aug 22, 2016: Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer
7.1.3 Aug 08, 2016: Valeant Pharmaceuticals Announces Changes To Executive Management Team
7.1.4 Jul 28, 2016: Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors
7.1.5 Jun 15, 2016: Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent Director
7.1.6 May 26, 2016: Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller
7.2 Financial Announcements
7.2.1 Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results
7.2.2 Aug 09, 2016: Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results
7.2.3 Jun 07, 2016: Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results
7.3 Legal And Regulatory
7.3.1 Aug 10, 2016: Valeant Pharmaceuticals Comments On SDNY Investigation
7.4 Other Significant Developments
7.4.1 Jun 17, 2016: Valeant Pharmaceuticals Announces Significant Investments In Canadian Operations
7.4.2 May 16, 2016: Valeant Pharmaceuticals Provides Update on Regulatory Matters
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Company Share Analysis
8.1.5 Distribution Share Analysis
8.1.6 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Cataract Surgery Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015
Table 2: Cataract Surgery Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 3: Ophthalmic Viscoelastic Devices (OVD) Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015
Table 4: Ophthalmic Viscoelastic Devices (OVD) Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 5: Cataract Surgery Devices Market, Canada, Volume (Units), Historic, 2008-2015
Table 6: Cataract Surgery Devices Market, Canada, Volume (Units), Forecast, 2015-2022
Table 7: Ophthalmic Viscoelastic Devices (OVD) Market, Canada, Volume (Units), Historic, 2008-2015
Table 8: Ophthalmic Viscoelastic Devices (OVD) Market, Canada, Volume (Units), Forecast, 2015-2022
Table 9: Cataract Surgery Devices Market, Canada, Average Price ($) Historic, 2008-2022
Table 10: Cataract Surgery Devices Market, Canada, Average Price ($), Forecast, 2015-2022
Table 11: Cataract Surgery Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 12: Cataract Surgery Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2015
Table 13: Cataract Surgery Devices Market Pipeline Products
Table 14: Valeant Pharma Rejects Joint Takeover Bid from Takeda Pharma and TPG Capital Management
1.2 List of Figures
Figure 1: Cataract Surgery Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 2: Cataract Surgery Devices Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 3: Ophthalmic Viscoelastic Devices (OVD) Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 4: Ophthalmic Viscoelastic Devices (OVD) Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 5: Cataract Surgery Devices Market, Canada, Volume (Units), Historic, 2008-2015
Figure 6: Cataract Surgery Devices Market, Canada, Volume (Units), Forecast, 2015-2022
Figure 7: Ophthalmic Viscoelastic Devices (OVD) Market, Canada, Volume (Units), Historic, 2008-2015
Figure 8: Ophthalmic Viscoelastic Devices (OVD) Market, Canada, Volume (Units), Forecast, 2015-2022
Figure 9: Cataract Surgery Devices Market, Canada, Company Share (%) 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report